Loop Industries, Inc. (LOOP) compared with its closest peers (LPCV, EQS, DXR, RAND, LODE). Peer set by Chemicals; 10 comparable chemical companies. First-party data.
Launchpad Cadenza Acquisition Corp I Class A Ordinary Share, Equus Total Return, Daxor, Rand Capital, Comstock, Lisata Therapeutics, Lipocine, Saratoga Investment, Live Oak Acquisition Corp. V Class A Ordinary Shares and Manhattan Bridge Capital share Loop Industries's business model, closed-end fund.
| Company | Market Cap | P/E |
|---|---|---|
| Launchpad Cadenza Acquisition Corp I Class A Ordinary Share (LPCV) | $50.23M | — |
| Equus Total Return, Inc. (EQS) | $14.39M | -1.4 |
| Daxor Corporation (DXR) | $45.19M | — |
| Rand Capital Corporation (RAND) | $31.98M | -4.3 |
| Comstock Inc. (LODE) | $247.74M | -3.2 |
| Lisata Therapeutics, Inc. (LSTA) | $14.15M | -1.0 |
| Lipocine Inc. (LPCN) | $19.54M | -4.8 |
| Saratoga Investment Corp. (SAR) | $299.14M | 19.0 |
| Live Oak Acquisition Corp. V Class A Ordinary Shares (LOKV) | $848.57M | — |
| Manhattan Bridge Capital, Inc. (LOAN) | $46.27M | 9.7 |
| Sector P/E (Materials) | 23.9 |
| Industry P/E (Chemicals) | 32.1 |
LOOP overview · LOOP earnings · LOOP financials · LOOP KPIs · LOOP documents · LOOP ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.